FDA approves new ADHD medication: 5 things to know
FDA approves new ADHD medication: 5 things to know Becker's Behavioral Health
2026
FDA Approves Perioperative Pembrolizumab-EV Regimen for MIBC
FDA Approves Perioperative Pembrolizumab-EV Regimen for MIBC Oncology Nursing News
FDA Approves Centanafadine for ADHD in Adults, Children Aged ≥ 6 Years
FDA Approves Centanafadine for ADHD in Adults, Children Aged ≥ 6 Years HCP Live
FDA Approves First NDSRI for ADHD in Adults and Children
FDA Approves First NDSRI for ADHD in Adults and Children Medscape
FDA Approves Blood-Based Test for Colorectal Cancer Screening
FDA Approves Blood-Based Test for Colorectal Cancer Screening CancerNetwork